Chromosomal genotype in breast cancer progression: Comparison of primary and secondary manifestations

Cellular Oncology

Volumn 30, Issue 1, 2008, Pages 39-50

  Friedrich, Katrin ^a   Weber, Theresa ^a   Scheithauer, Jens ^a   Meyer, Wolfdietrich ^a   Haroske, Gunter ^b   Kunze, Klaus Dietmar ^a   Baretton, Gustavo ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

Author keywords

Breast cancer; Comparative genomic hybridization; Local recurrences; Metastases

Indexed keywords

ARTICLE; BREAST CANCER; CANCER RECURRENCE; CARCINOGENESIS; CHROMOSOME; CHROMOSOME 12Q; CHROMOSOME 14Q; CHROMOSOME 17Q; CHROMOSOME 5P; CHROMOSOME 7Q; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENOTYPE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

BREAST NEOPLASMS; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; DISEASE PROGRESSION; GENOTYPE; HUMANS; LYMPHATIC METASTASIS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; TISSUE ARRAY ANALYSIS;

EID: 38549091477     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. M. Aubele, G. Auer, H. Braselmann, J. Nährig, H. Zitzelsberger, L. Quintanilla-Martinez, J. Smida, A. Walch, H. Höfler and M. Werner, Chromosomal imbalances are associated with metastasis-free survival in breast cancer patients, Anal. Cell. Pathol. 24 (2002), 77-87.
2. M. Aubele, A. Mattis, H. Zitzelsberger, A. Walch, M. Kremer, P. Hutzler, H. Höfler and M. Werner, Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization, Cancer Genet. Cytogenet. 110 (1999), 94-102.
3. M. Aubele, A. Mattis, H. Zitzelsberger, A. Walch, M. Kremer, G. Welzl, H. Höfler and M. Werner, Extensive ductal carcinoma in situ with small foci of invasive ductal carcinoma: evidence of genetic resemblance by CGH, Int. J. Cancer 85 (2000), 82-86.
4. T.A. Buchholz, S.L. Tucker, L. Masullo, H.M. Kuerer, J. Erwin, J. Salas, D. Frye, E.A. Strom, M.D. McNeese, G. Perkins, A. Katz, S.E. Singletary, K.K. Hunt, A.U. Buzdar and G.N. Hortobagyi, Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomie without radiation, J. Clin. Oncol. 20 (2001), 17-23.
5. A. Dellas, J. Torhorst, E. Schultheiss, M.J. Mihatsch and H. Moch, DNA sequence losses on chromosome 11p and 18q are associated with clinical outcome in lymph node-negative ductal breast cancer, Clin. Cancer Res. 8 (2002), 1210-1216.
6. G. Deng, Y. Lu, G. Zlotnikov, A.D. Thor and H.S. Smith, Loss of heterozygosity in normal tissue adjacent to breast carcinomas, Science 274 (1996), 2057-2059.
7. I.J. Fidler, Critical determinants of metastasis, Semin. Cancer Biol. 12 (2002), 89-96.
8. B. Fowble, Ipsilateral breast tumors recurrence following breast-conserving surgery for early-stage invasive cancer, Acta Oncol. Suppl. 13 (1999), 9-17.
9. K. Friedrich, J. Scheithauer, V. Dimmer, W. Meyer, F. Theissig, G. Haroske and K.D. Kunze, DNA ploidy and chromosomal imbalances in invasive ductal breast cancer. A comparative study of DNA image cytometry and comparative genomic hybridization (CGH), Anal. Cell. Pathol. 20 (2000), 69-82.
10. V.V. Glinsky, G.V. Glinsky, O.V. Glinsky, V.H. Huxley, J.R. Turk, V.V. Mossine, S.L. Deutscher, K.J. Pienta and T.P. Quinn, Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium, Cancer Res. 63 (2003), 3805-3811.
11. N.S. Goldstein, L. Kestin and F. Vicini, Factors associated with ipsilateral breast failure and distant metastases in patients with invasive breast carcinoma treated with breast-conserving therapy, Am. J. Clin. Pathol. 120 (2003), 500-527.
12. J.J. Isola, O.-P. Kallioniemi, L.W. Chu, S.A.W. Fuqua, S.G. Hilsenbeck, C.K. Osborne and F.M. Waldman, Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer, Am. J. Pathol. 147 (1995), 905-911.
13. A. Kallioniemi, O.-P. Kallioniemi, D. Sudar, D. Rutovitz, J.W. Gray, F. Waldman and D. Pinkel, Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors, Science 258 (1992), 818-821.
14. Z. Li, D.H. Moore, Z.H. Meng, B.-M. Ljung, J.W. Gray and S.H. Dairkee, Increased risk of local recurrence is associated with allelic loss in normal lobules of breast cancer patients, Cancer Res. 62 (2002), 1000-1003.
15. S. du Manoir, M.R. Speicher, S. Joos, E. Schröck, S. Popp, H. Döhner, G. Kovacs, M. Robert-Nicoud, P. Lichter and T. Cremer, Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization, Hum. Genet. 90 (1993), 590-610.
16. D. Niederacher, F. Picard, C. van Roeyen, H.X. An, H.G. Bender and M.W. Beckmann, Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatelite analysis, Genes Chromosomes Cancer 18 (1997), 181-192.
17. T. Nishizaki, S. DeVries, K. Chew, W.H. Goodson III, B.-M. Ljung, A. Thor and F.M. Waldman, Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization, Genes Chromosomes Cancer 19 (1997), 267-272.
18. N. Pandis, M.R. Teixeira, A. Adeyinka, H. Rizou, G. Bardi, F. Mertens, J.A. Andersen, L. Bondeson, K. Sfikas, H. Qvist, N. Apostolikas, F. Mitelman and S. Heim, Cytogenetic comparison of primary tumors and lymph node metastases in breast cancer patients, Genes Chromosomes Cancer 22 (1998), 122-129.
19. I. Petersen, H. Langreck, G. Wolf, A. Schwendel, R. Psille, P. Vogt, M.B. Reichel, T. Ried and M. Dietel, Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p, Br. J. Cancer 75 (1997), 79-86.
20. S. Ramaswamy, K.N. Ross, E.S. Lander and T.R. Golub, A molecular signature of metastasis in primary solid tumors, Nat. Genet. 33 (2003), 49-54.
21. T. Ried, K. Heselmeyer-Haddad, H. Blegen, E. Schröck and G. Auer, Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a pheno-type/genotype correlation, Genes Chromosomes Cancer 25 (1999), 195-204.
22. K. Roth, G. Wolf, M. Dietel and I. Petersen, Analyseprogramm zur quantitativen Erfassung chromosomaler Aberrationen mittels komparativer genomischer Hybridisierung (CGH), Pathologe 17 (1996), 342-348.
23. S.J. Schnitt, Risk factors for local recurrence in patients with invasive breast cancer and negative surgical margins of excision, Am. J. Clin. Pathol. 120 (2003), 485-488.
24. L.J. van't Veer, H. Dai, M.J. van de Vijver, Y.D. He, A.A. Hart, M. Mao, H.L. Peterse, K. van der Kooy, M.J. Marton, A.T. Witteveen, G.J. Schreiber, R.M. Kerkhoven, C. Roberts, P.S. Linsley, R. Berards and S.H. Friend, Gene expression profiling predicts clinical outcome of breast cancer, Nature 415 (2002), 530-536.
25. L.J. van't Veer and B. Weigelt, Road map of metastasis, Nat. Med. 9 (2003), 999-1000.
26. A.C. Voogd, M. Nielsen, J.L. Petrse, M. Blichert-Toft, H. Bartelink, M. Overgaard, G. van Tienhoven, K.W. Andersen, R.J. Sylvester and J.A. van Dongen, Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials, J. Clin. Oncol. 19 (2001), 1688-1697.
27. W. Wang, J.B. Wyckhoff, V.C. Frohlich, Y. Oleynikov, S. Hüttelmaier, J. Zavadil, L. Cermak, E.P. Bottinger, R.H. Singer, J.G. White, J.E. Segall and J.S. Condeelis, Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling, Cancer Res. 62 (2002), 6278-6288.
28. Y. Wang, J.G. Klijn, Y. Zhang, A.M. Sieuwerts, M.P. Look, F. Yang, D. Talantov, M. Timmermans, M.E. Meijer-van Gelder, J. Yu, T. Jatkoe, E.M. Berns, D. Atkins and J.A. Foekens, Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer, Lancet 365 (2005), 671-679.
29. B. Weigelt, Z. Hu, X. He, C. Livasy, L.A. Carey, M.G. Ewend, A.M. Glas, C.M. Perou and L.J. van't Veer, Molecular portraits and 70-gene prognosis signature are preserved through-out the metastatic process of breast cancer, Cancer 65 (2005), 9155-9158.
30. C.S.M. Williams, R.D. Leek, A.M. Robson, S. Banerji, R. Prevo, A.L. Harris and D.G. Jackson, Absence of lymphangiogenesis and intratumoral lymph vessels in human metastatic breast cancer, J. Pathol. 200 (2003), 195-206.
31. U. Woelfle, J. Cloos, G. Sauter, L. Riethdorf, F. Jänicke, P. van Diest, R. Brakenhoff and K. Pantel, Molecular signature associated with bone marrow micrometastases in human breast cancer, Cancer Res. 63 (2003), 5679-5684.